The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTUNG.L Regulatory News (TUNG)

  • There is currently no data for TUNG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

3 Mar 2016 15:49

RNS Number : 0050R
Tungsten Corporation PLC
03 March 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Tungsten Corp Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Morgan Stanley

(Institutional Securities Group and Global Wealth Management)

4. Full name of shareholder(s)  (if different from 3.):iv

Morgan Stanley & Co. International plc

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

01.03.2016

6. Date on which issuer notified:

03.03.2016

7. Threshold(s) that is/are crossed orreached: vi, vii

8%

 

 

 

 

 

 

 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

GB00B7Z0Q502

 

5,617,809

 

 

5,617,809

 

 

6,236,728

 

 

6,236,728

 

4.95%

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

Right of Recall over a securities lending agreement

N/A

N/A

 

395,035

 

0.31%

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Equity Swap (Cash-Settled)

N/A

 

16/03/2016

 

N/A

 

 

3,500,000

 

 

Nominal

Delta

N/A

2.78%

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

10,131,763

 

 

8.04%

 

 

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

Morgan Stanley & Co. International plc, 25 Cabot Square, Canary Wharf, London E14 4QA is a direct holder of

9,800,955 voting rights (7.77%) and is a subsidiary of Morgan Stanley Investments (UK)

 

Morgan Stanley Investments (UK), 20 Bank Street, Canary Wharf, London E14 4AD is an indirect holder of

9,800,955 voting rights (7.77%) and is a subsidiary of Morgan Stanley UK Group

 

Morgan Stanley UK Group, 25 Cabot Square, Canary Wharf, London E14 4QA is an indirect holder of

9,800,955 voting rights (7.77%) and is a subsidiary of Morgan Stanley International Limited

 

Morgan Stanley International Limited, 25 Cabot Square, Canary Wharf, London E14 4QA is an indirect holder of

9,800,955 voting rights (7.77%) and is a subsidiary of Morgan Stanley International Holdings Inc.

 

Morgan Stanley International Holdings Inc., c/o The Corporation Trust Company (DE), Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware 19801, USA is an indirect holder of 9,800,955 voting rights (7.77%) and is a subsidiary of the beneficial owner Morgan Stanley

 

Proxy Voting:

10. Name of

 the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

14. Contact name:

Craig Horsley

15. Contact telephone number:

0141 245 7736

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUGURCWUPQGAW
Date   Source Headline
31st Jul 20181:54 pmRNSHolding(s) in Company
27th Jul 20181:14 pmRNSGrant of Share Options
24th Jul 20185:48 pmRNSAnnual Report & Accounts Uploaded to Website
23rd Jul 20187:00 amRNSFinal Results for the year ended 30 April 2018
20th Jul 20183:22 pmRNSRequisition Update & Proposed Board Appointments
10th Jul 20189:00 amRNSLaunch of billing service for Accounts Receivable
4th Jul 20185:25 pmRNSExercise of Options / Additional Listing
29th Jun 20184:32 pmRNSNotice of Requisition of General Meeting
27th Jun 201810:25 amRNSTungsten Network > £300m financing since relaunch
14th Jun 20187:00 amRNSComment on press speculation
6th Jun 20182:14 pmRNSHolding(s) in Company
4th Jun 20187:00 amRNSTrading Update
21st May 20183:54 pmRNSNotice of Pre-Close Trading Update & FY18 Results
8th May 20187:00 amRNSHolding(s) in Company - Indus Capital
20th Apr 20187:47 amRNSHolding(s) in Company - DCIL
5th Feb 20187:00 amRNSHolding(s) in Company
8th Jan 20187:00 amRNSTungsten Network Finance accelerates growth
14th Dec 20177:00 amRNSInterim Results for six months to 31 October 2017
1st Dec 20179:00 amRNSNotice of Interim Results
4th Oct 20172:19 pmRNSHolding(s) in Company
15th Sep 20174:53 pmRNSResult of AGM
15th Sep 20177:00 amRNSAGM Statement & Trading Update
7th Sep 201710:18 amRNSHolding(s) in Company
16th Aug 20177:00 amRNSMailing of Annual Report and Notice of AGM
11th Aug 201712:07 pmRNSSecond Price Monitoring Extn
11th Aug 201712:02 pmRNSPrice Monitoring Extension
4th Aug 20178:01 amRNSDirector/PDMR Shareholding-Grant of Share Options
24th Jul 20177:00 amRNSFinancial Report for 12 months ended 30 April 2017
13th Jun 201712:07 pmRNSSecond Price Monitoring Extn
13th Jun 201712:02 pmRNSPrice Monitoring Extension
24th May 20177:01 amRNSDirectorate Change
24th May 20177:00 amRNSPre-close FY17 Trading Update
17th May 20171:15 pmRNSNotice of Pre-Close Trading Update & FY17 Results
15th May 201712:07 pmRNSSecond Price Monitoring Extn
15th May 201712:02 pmRNSPrice Monitoring Extension
3rd May 20177:00 amRNSDirector/PDMR Shareholding - Nick Parker
7th Apr 20174:40 pmRNSSecond Price Monitoring Extn
7th Apr 20174:35 pmRNSPrice Monitoring Extension
30th Jan 20177:07 amRNSDirector/PDMR Shareholding
10th Jan 201710:41 amRNSHolding(s) in Company
22nd Dec 20167:00 amRNSCompletion of Bank Sale
21st Dec 201612:55 pmRNSHolding(s) in Company
20th Dec 20169:35 amRNSDirector/PDMR Shareholding
14th Dec 20167:00 amRNSHalf-year Report
16th Nov 20167:00 amRNSSale of Tungsten Bank Receives Regulatory Approval
1st Nov 20167:00 amRNSUpdate on Sale of Tungsten Bank
19th Oct 20162:22 pmRNSHolding(s) in Company
17th Oct 20167:00 amRNSDirector/PDMR Shareholding
13th Oct 20169:37 amRNSSettlement of Tax
21st Sep 20166:11 pmRNSDirector/PDMR Shareholding - David Benello

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.